Cargando…
Using zebrafish to shed light on melanoma: an interview with Liz Patton
Liz Patton is a Senior Lecturer at the MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, where she leads a research group whose goal is to understand melanocyte and melanoma development. Early on in her research career, Liz investigated cell cycle regulation in yeast and the...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820254/ https://www.ncbi.nlm.nih.gov/pubmed/24203994 http://dx.doi.org/10.1242/dmm.014340 |
_version_ | 1782290110828511232 |
---|---|
collection | PubMed |
description | Liz Patton is a Senior Lecturer at the MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, where she leads a research group whose goal is to understand melanocyte and melanoma development. Early on in her research career, Liz investigated cell cycle regulation in yeast and the implications for cancer, but now primarily exploits the zebrafish model to identify new pathways and therapeutic compounds relevant to melanoma. In this interview, Liz recalls some of her most exciting breakthroughs to date, discusses the advantages of zebrafish as a disease model and provides her perspectives on the current challenges in cancer research. |
format | Online Article Text |
id | pubmed-3820254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | The Company of Biologists Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-38202542013-11-07 Using zebrafish to shed light on melanoma: an interview with Liz Patton Dis Model Mech A Model for Life Liz Patton is a Senior Lecturer at the MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, where she leads a research group whose goal is to understand melanocyte and melanoma development. Early on in her research career, Liz investigated cell cycle regulation in yeast and the implications for cancer, but now primarily exploits the zebrafish model to identify new pathways and therapeutic compounds relevant to melanoma. In this interview, Liz recalls some of her most exciting breakthroughs to date, discusses the advantages of zebrafish as a disease model and provides her perspectives on the current challenges in cancer research. The Company of Biologists Limited 2013-11 /pmc/articles/PMC3820254/ /pubmed/24203994 http://dx.doi.org/10.1242/dmm.014340 Text en © 2013. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | A Model for Life Using zebrafish to shed light on melanoma: an interview with Liz Patton |
title | Using zebrafish to shed light on melanoma: an interview with Liz Patton |
title_full | Using zebrafish to shed light on melanoma: an interview with Liz Patton |
title_fullStr | Using zebrafish to shed light on melanoma: an interview with Liz Patton |
title_full_unstemmed | Using zebrafish to shed light on melanoma: an interview with Liz Patton |
title_short | Using zebrafish to shed light on melanoma: an interview with Liz Patton |
title_sort | using zebrafish to shed light on melanoma: an interview with liz patton |
topic | A Model for Life |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820254/ https://www.ncbi.nlm.nih.gov/pubmed/24203994 http://dx.doi.org/10.1242/dmm.014340 |